| Net Cash Provided by (Used in) Operating Activities |
$619,000,000 |
USD |
5.1% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$98,000,000 |
USD |
-89% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$715,000,000 |
USD |
53% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
137,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$10,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$639,000,000 |
USD |
-1.5% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$83,000,000 |
USD |
-19% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$3,275,000,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,141,000,000 |
USD |
-617% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$2,328,000,000 |
USD |
2.1% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$656,000,000 |
USD |
13% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$983,000,000 |
USD |
-28% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$58,000,000 |
USD |
-7.9% |
Q4 2024 |
FY 2024 |
| Operating Lease, Payments |
$235,000,000 |
USD |
-12% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$6,623,000,000 |
USD |
0.12% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$25,000,000 |
USD |
-19% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,698,000,000 |
USD |
-0.74% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$21,000,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$358,000,000 |
USD |
21% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |